These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3811724)

  • 41. Dystrophin and Duchenne's muscular dystrophy.
    Hurko O; Johns DR
    N Engl J Med; 1989 Aug; 321(6):398-9. PubMed ID: 2664525
    [No Abstract]   [Full Text] [Related]  

  • 42. Methandrostenolone and nandrolone decanoate in muscular dystrophy; a controlled trial.
    BARWICK DD; NEWELL DJ; WALTON JN
    Neurology; 1963 Jan; 13():12-23. PubMed ID: 13969794
    [No Abstract]   [Full Text] [Related]  

  • 43. Leber's congenital amaurosis with Duchenne's muscular dystrophy.
    Hazariwala K; Brownstein S; Polomeno R; Little JM; Labuda D
    Can J Ophthalmol; 1990 Jun; 25(4):202-7. PubMed ID: 1972344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The diagnosis and treatment of Duchenne muscular dystrophy.
    Winters JL; McLaughlin LA
    South Med J; 1970 May; 63(5):530-2. PubMed ID: 5446821
    [No Abstract]   [Full Text] [Related]  

  • 45. Pulmonary care of Duchenne type of muscular dystrophy.
    Aberion G; Alba A; Lee MH; Solomon M
    N Y State J Med; 1973 May; 73(10):1206-7. PubMed ID: 4512245
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evolution profiles of untreated Duchenne's dystrophy].
    Rideau Y
    Union Med Can; 1979 Jan; 108(1):61, 63-5 68. PubMed ID: 432982
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical polymorphism and genetic heterogeneity in Duchenne's progressive muscular dystrophy in girls (a review)].
    Zavadenko NN; Temin PA; Malygina NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):123-6. PubMed ID: 3066079
    [No Abstract]   [Full Text] [Related]  

  • 48. [Diagnostic value of determining lactate dehydrogenase in the blood in progressive muscular dystrophy of the Duchenne type and in detection of the carrier state of this disease].
    Niebrój-Dobosz I
    Neurol Neurochir Pol; 1985; 19(3):227-30. PubMed ID: 4047301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duchenne's muscular dystrophy: carrier detection by imaging technics.
    Rott HD; Rödl W; Santellani M; Nebel G
    J Genet Hum; 1984 Sep; 32(4):287-90. PubMed ID: 6387044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Muscular dystrophy: from pathogenesis to strategy.
    Hsu YD
    Acta Neurol Taiwan; 2004 Jun; 13(2):50-8. PubMed ID: 15478675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A benign variant of the course of Duchenne muscular dystrophy in a child with short stature].
    Badalian LO; Temin PA; Kamennykh LN; Zavadenko NN; Nikanorova MIu; Arkhipov BA; Malygina NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(8):94-7. PubMed ID: 1661530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy.
    Hoffman EP; Fischbeck KH; Brown RH; Johnson M; Medori R; Loike JD; Harris JB; Waterston R; Brooke M; Specht L
    N Engl J Med; 1988 May; 318(21):1363-8. PubMed ID: 3285207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. X-linked recessive (Duchenne) muscular dystrophy and purine metabolism.
    Thomson WH; Smith I
    Lancet; 1976 Oct; 2(7989):805-6. PubMed ID: 61479
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinico-morphologic characteristics of X-linked pseudohypertrophic myopathy].
    Demidov PV; Kop'eva TN; Potomskaia IZ; Grinio LP; Kopylova EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(5):641-6. PubMed ID: 936862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of deletions in the dystrophin gene by the multiplex amplification method in patients suffering from Duchenne's muscular dystrophy].
    Malysheva OV; Poliakov AV; Zaĭtseva SP; Malygina NA; Gorbunova VN; Evgrafov OV; Makarov VG; Krasil'nikov VV; Baranov VS; Vadalian LO
    Mol Gen Mikrobiol Virusol; 1992; (5-6):27-31. PubMed ID: 1454081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rhabdomyolysis in association with Duchenne's muscular dystrophy.
    Obata R; Yasumi Y; Suzuki A; Nakajima Y; Sato S
    Can J Anaesth; 1999 Jun; 46(6):564-6. PubMed ID: 10391604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [DNA markers, genetic counseling and prenatal diagnosis of hereditary disease. A study of 3 families with Duchenne's muscular dystrophy].
    Schwartz M; Nørby S; Brandt NJ
    Ugeskr Laeger; 1985 Jun; 147(26):2071-5. PubMed ID: 3863357
    [No Abstract]   [Full Text] [Related]  

  • 59. [DNA markers, genetic counseling and prenatal diagnosis of hereditary diseases. A study of 3 families with Duchenne's muscular dystrophy].
    Schwartz M; Nørby S; Brandt NJ
    Ugeskr Laeger; 1985 Jul; 147(30):2382-6. PubMed ID: 3864307
    [No Abstract]   [Full Text] [Related]  

  • 60. [Carrier detection and prenatal diagnosis of Duchenne's muscular dystrophy based on DNA analysis].
    Evgrafov OV; Badalian LO; Poliakov AV; Zaĭtseva SP; Malygina NA; Vinogradov SV; Bakharev VA; Mil'man FA; Lisova LP; Zaretskaia NV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(8):29-33. PubMed ID: 2175114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.